Retitrutide Molecule and Consultation

R-50 – Retatrutide Molecule (Prescription Only)

Dual Options: 10mg (1mL) & 50mg (5mL)

Triple Incretin Therapy for Fat Loss, Appetite Control & Metabolic Reset

Formulations Available:

• R-10: 10mg Retatrutide (1mL vial – 10mg/mL concentration)

• R-50: 50mg Retatrutide (5mL vial – 10mg/mL concentration)
  
  Classification: Prescription Only – Requires Clinical Consultation

R-50 delivers the Retatrutide molecule, a first-in-class triple incretin agonist that activates GLP-1, GIP, and glucagon receptors to support maximum fat loss, appetite suppression, and metabolic enhancement. This next-generation peptide has shown the highest weight loss potential of any medication studied to date, with reductions in body weight exceeding 24% in early clinical trials.

Both R-10 and R-50 require provider approval through Arizona Sports Medicine or a PROpeptides-affiliated clinician prior to shipping.

🔬 Key Research-Based Mechanisms

🔥 Triple Incretin Activation for Body Fat Loss
Simultaneous activation of GLP-1, GIP, and glucagon receptors enhances satiety, reduces food intake, and accelerates fat breakdown.
📖 Jastreboff et al., 2023 (NEJM) – Participants experienced up to 24.2% total body weight loss over 48 weeks with Retatrutide.

🩸 Improved Glycemic Control & Insulin Sensitivity
Retatrutide lowers fasting glucose, improves insulin signaling, and reduces HbA1c—making it ideal for prediabetes and metabolic syndrome.
📖 Frias et al., 2023 (Diabetes Care) – Documented HbA1c reductions of 2.2% and improved insulin function.

🧠 Appetite Suppression & Food Craving Reduction
GLP-1 and GIP activity reduce central appetite signaling and compulsive eating behavior.
📖 Killion et al., 2022 – Triple incretins blunt hedonic drive and increase satiety in preclinical models.

🧬 Enhanced Fat Oxidation & Energy Expenditure
Glucagon receptor activation increases metabolic rate and supports lean mass preservation during weight loss.
📖 Gil-Lozano et al., 2021 – Glucagon agonism maintained basal metabolic rate and increased fat burning in animal models.

⚕️ Clinical Access & Prescription Protocol

This medication is not available without a prescription. A telehealth consult is required prior to dispensing, and dosage will be determined by your licensed provider based on medical history, goals, and lab results.

✅ Prescription required
✅ Provider consult included
✅ IGF-1, HbA1c, and metabolic labs may be recommended
✅ Follow-up and titration guidance included

💉 Dosing Protocol

Both vial options contain 10mg/mL Retatrutide. Choose your volume based on treatment duration and frequency:

Typical Starting Dose: 20 units weekly (1mg)
Titration Plan: Increase by 10 units (0.5mg) every 1–2 weeks, only if tolerated and weight loss plateaus
Route: Subcutaneous injection (abdomen preferred)
Cycle Length: 3–6 months recommended, with reassessment every 4–8 weeks
Stack Compatibility: Often combined with KPV, Tesamorelin, MOTS-C, or GHK-Cu for enhanced metabolic and recovery support

📦 What’s Included With Every Order

✅ 1 x Retatrutide vial (choose R-10 or R-50)
✅ Pre-measured bacteriostatic water
✅ Insulin syringes + alcohol swabs
✅ Sharps container bag
✅ Full printed guide: titration, storage, injection protocol
✅ Follow-up access to licensed prescribing provider

📧 Questions? Email: Admin@Propeptides.com
📞 Call/Text: 480-400-6225

🛡️ Aggressive Fat Loss. Medical Oversight. Real Results.

Whether you’re seeking to overcome a metabolic plateau or want the most advanced weight loss molecule available, R-50 (Retatrutide) is the prescription-based solution trusted by progressive medical providers for safe, monitored body recomposition.

Choose R-10 to start slow. Choose R-50 for sustained results.
All options include provider consultation and support.